Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

5α-reductase 2 is crucial for stress response in male rats.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Alcohol in teen years leads to more adult drinking, finasteride doesn't help.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

Pharmacists play a crucial role in health literacy and patient care.

Allopregnanolone likely doesn't influence ethanol's rewarding effects in these mice.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

Dextroamphetamine may help treat alopecia areata.

Finasteride may cause changes in dopamine-related genes, possibly leading to post-finasteride syndrome.

Dopaminergic neurons in the gut have diverse subtypes with different neurotransmitter contents.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

Dopaminergic neurons in the gut have distinct subtypes, some releasing both dopamine and acetylcholine.

Neurosteroids help control dopamine responses in the brain.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Schizophrenia patients' stem cells show abnormal neuron development and mitochondrial issues.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Dopamine affects coat color changes in agouti mice.

Trichotillomania treatment is improving with new therapies, but challenges like stigma and lack of training remain.

Trichotillomania involves hair-pulling due to brain and genetic factors, with behavior therapy and new drugs showing promise, but challenges like stigma and underdiagnosis persist.

Trichotillomania treatment is improving with behavior therapy and new drug approaches, but challenges like stigma and underdiagnosis remain.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Hair follicle and adipose cell vesicles both protect neurons and reduce inflammation similarly.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.

Finasteride reduces movement issues in Parkinson's disease rats.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Neurosteroids may help treat disorders with too much dopamine activity.